Andrew John Armstrong
Andrew John Armstrong

Andrew John Armstrong

Professor of Medicine


I am a clinical and translational investigator focused on precision therapies and biomarkers in advanced prostate and other GU cancers.  I oversee a large research team of clinical and lab based investigators focused on improving patient outcomes, preventing metastatic disease, and understanding the biology of aggressive prostate cancer.  Some key themes:
1. Predictors of sensitivity and clinical efficacy of therapies in advanced prostate cancer
2. Novel designs of clinical trials and pharmacodynamic/translational studies in prostate, kidney, bladder cancer
3. Pre-operative models for drug development of novel agents in human testing in prostate cancer
4. Novel therapies and drug development for prostate, renal, bladder, and testicular cancer
5. Design of rational combination therapies in men with metastatic hormone-refractory prostate cancer
6. Developing prognostic and predictive models for progression and survival in metastatic prostate cancer
7. Examining surrogate markers of mortality in metastatic prostate cancer
8. Clear cell and non-clear cell renal cell carcinoma: natural history, sensitivity to novel agents including mTOR and VEGF inhibition


Professor of Medicine in the School of Medicine

2018 School of Medicine

Professor in Pharmacology and Cancer Biology in the School of Medicine

2021 School of Medicine

Professor in Urology in the School of Medicine

2018 School of Medicine

Member of the Duke Cancer Institute in the School of Medicine

2006 School of Medicine


B.S.E. 1996

1996 Duke University

M.D. 2000

2000 University of Virginia, School of Medicine

M.Sc. 2008

2008 Johns Hopkins University


2003 University of Pennsylvania, School of Medicine


2006 Johns Hopkins University, School of Medicine

Publications, Grants & Awards

DCI Centers, Cancer Types & Labs

Offices & Contact

GSRB1 Room 3006
Durham, NC
Duke Box 103861
Durham, NC